Next Article in Journal
Detection of Ricin Contamination in Ground Beef by Electrochemiluminescence Immunosorbent Assay
Next Article in Special Issue
A Comparison of the Anti-Tumor Effects of a Chimeric versus Murine Anti-CD19 Immunotoxins on Human B Cell Lymphoma and Pre-B Acute Lymphoblastic Leukemia Cell Lines
Previous Article in Journal
Cycle Inhibiting Factors (Cifs): Cyclomodulins That Usurp the Ubiquitin-Dependent Degradation Pathway of Host Cells
Previous Article in Special Issue
Imaging of Convection Enhanced Delivery of Toxins in Humans
Toxins 2011, 3(4), 369-397; doi:10.3390/toxins3040369
Review

The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology

* ,
 and
Received: 28 February 2011; in revised form: 25 March 2011 / Accepted: 25 March 2011 / Published: 31 March 2011
(This article belongs to the Special Issue Immunotoxins)
View Full-Text   |   Download PDF [663 KB, updated 1 April 2011; original version uploaded 31 March 2011]   |   Browse Figures
Abstract: Liposomes have long been effective delivery vehicles for transport of toxins to peripheral cancers. The combination of convection-enhanced delivery (CED) with liposomal toxins was originally proposed to circumvent the limited delivery of intravascular liposomes to the central nervous system (CNS) due to the blood-brain-barrier (BBB). CED offers markedly improved distribution of infused therapeutics within the CNS compared to direct injection or via drug eluting polymers, both of which depend on diffusion for parenchymal distribution. This review examines the basis for improved delivery of liposomal toxins via CED within the CNS, and discusses preclinical and clinical experience with these therapeutic techniques. How CED and liposomal technologies may influence future neurooncologic treatments are also considered.
Keywords: blood-brain-barrier; convection-enhanced delivery; diffusion; glioma; liposome; neurooncology blood-brain-barrier; convection-enhanced delivery; diffusion; glioma; liposome; neurooncology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Fiandaca, M.S.; Berger, M.S.; Bankiewicz, K.S. The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology. Toxins 2011, 3, 369-397.

AMA Style

Fiandaca MS, Berger MS, Bankiewicz KS. The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology. Toxins. 2011; 3(4):369-397.

Chicago/Turabian Style

Fiandaca, Massimo S.; Berger, Mitchel S.; Bankiewicz, Krystof S. 2011. "The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology." Toxins 3, no. 4: 369-397.


Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert